Expansion of CpG methylation in the SFRP2 promoter region during colorectal tumorigenesis

Acta Medica Okayama

Volumn 65, Issue 3, 2011, Pages 169-177

  Takeda, Masanori ^a   Nagasaka, Takeshi ^a   Dong Sheng, Sun ^a   Nishie, Hiroyuki ^a   Oka, Tetsuhiro ^a   Yamada, Eiji ^a   Mori, Yoshiko ^a   Shigeyasu, Kunitoshi ^a   Morikawa, Tatsuya ^a   Mizobuchi, Satoshi ^a   Fujiwara, Toshiyoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

BRAF KRAS mutations; Colorectal cancer; Promoter methylation

Indexed keywords

MEMBRANE PROTEIN; SFRP2 PROTEIN, HUMAN;

AGED; ARTICLE; COLON; COLORECTAL TUMOR; CPG ISLAND; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; METHYLATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION;

AGED; COLON; COLORECTAL NEOPLASMS; CPG ISLANDS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MALE; MEMBRANE PROTEINS; METHYLATION; MIDDLE AGED; PROMOTER REGIONS, GENETIC;

EID: 79960142814     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Fodde R, Smits R and Clevers H: APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer (2001) 1: 55-67.
2. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H: Constitutive transcrip-tional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 275: 1784-1787.
3. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science (1997) 275: 1787-1790.
4. Jones SE and Jomary C: Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays (2002) 24: 811-820.
5. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB: A genomic screen for genes upregulated by demethylation and histone deacetylase inhi bition in human colorectal cancer. Nat Genet (2002) 31: 141-149.
6. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG and Baylin SB: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 36: 417-422.
7. Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knuchel R and Dahl E: Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol Cancer (2008) 7: 83.
8. NagasakaT, Koi M, Kloor M, Gebert J, Vilkin A, Nishida N, Shin SK, Sasamoto H, Tanaka N, Matsubara N, Boland CR and Goel A: Mutations in both KRAS and BRAF may contribute to the meth-ylator phenotype in colon cancer. Gastroenterology (2008) 134: 1950-1960, 1960 e1.
9. Nishida N, NishimuraT, NagasakaT, Ikai I, Goel A and Boland CR: Extensive methylation is associated with beta-catenin muta tions in hepatocellular carcinoma: evidence for two distinct path ways of human hepatocarcinogenesis. Cancer Res (2007) 67: 4586-4594.
10. Nishida N, NagasakaT, NishimuraT, Ikai I, Boland CR and Goel A: Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology(2008)47: 908-918.
11. Nagasaka T, Tanaka N, Cullings HM, Sun DS, Sasamoto H, Uchida T, Koi M, Nishida N, Naomoto Y, Boland CR, Matsubara N and Goel A: Analysis of fecal DNA methylation to detect gastro intestinal neoplasia. J Natl Cancer Inst (2009) 101: 1244-1258.
12. MullerHM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, Muhlthaler M, Ofner D, Margreiter R and Widschwendter M: Methylation changes in faecal DNA: a marker for colorectal can cer screening? Lancet (2004) 363: 1283-1285
13. Oberwalder M, Zitt M, Wontner C, Fiegl H, Goebel G, Zitt M, Kohle O, Muhlmann G, Ofner D, Margreiter R and Muller HM: SFRP2 methylation in fecal DNA-a marker for colorectal polyps. Int J Colorectal Dis (2007).
14. Nagasaka T, Goel A, Notohara K, Takahata T, Sasamoto H, Uchida T, Nishida N, Tanaka N, Boland CR and Matsubara N: Methylation pattern of the O(6)-methylguanine-DNA methyltrans-ferase gene in colon during progressive colorectal tumorigenesis. Int J Cancer (2008) 122: 2429-2436.
15. NagasakaT, Sasamoto H, Notohara K, Cullings HM, Takeda M, Kimura K, Kambara T, MacPhee DG, Young J, Leggett BA, Jass JR, Tanaka N and Matsubara N: Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol (2004) 22: 4584-4594.
16. Brophy PD, Lang KM and Dressier GR: The secreted frizzled related protein 2 (SFRP2) gene is a target of the Pax2 transcription factor. J Biol Chem (2003) 278: 52401-52405.
17. Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ and Gazdar AF: Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res (2002)62: 3382-3386.
18. Toyooka S, Suzuki M, Tsuda T, Toyooka KO, Maruyama R, Tsukuda K, Fukuyama Y, lizasa T, Fujisawa T, Shimizu N, Minna JD and Gazdar AF: Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer (2004) 110: 462-464.
19. Katayama H, Hiraki A, Aoe K, Fujiwara K, Matsuo K, Maeda T, Murakami T, Toyooka S, Sugi K, Ueoka H and Tanimoto M: Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion. Int J Cancer (2007) 120: 2191-2195.
20. IssaJP, OttavianoYL, Celano P, Hamilton SR, Davidson NE and Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 7: 536-540.
21. Miyakura Y, Sugano K, Konishi F, Ichikawa A, Maekawa M, Shitoh K, Igarashi S, Kotake K, Koyama Y and Nagai H: Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenter-ology (2001) 121: 1300-1309.
22. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, EinspahrJG, Buckmeier J, Alberts DS, Hamilton SR and Issa JP: MGMT promoter methy lation and field defect in sporadic colorectal cancer. J Natl Cancer Inst (2005) 97: 1330-1338.
23. Ushijima T, Watanabe N, Shimizu K, Miyamoto K, Sugimura T and Kaneda A: Decreased fidelity in replicating CpG methylation patterns in cancer cells. Cancer Res (2005) 65: 11-17.
24. Ushijima T and Okochi-Takada E: Aberrant methylations in cancer cells: where do they come from? Cancer Sci (2005) 96: 206-211.
25. Nagasaka T, Rhees J, Kloor M, Gebert J, Naomoto Y, Boland CR and Goel A: Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. Cancer Res (2010) 70: 3098-3108.
26. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR and Leggett BA: BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 53: 1137-1144.
27. Chan TL, Zhao W, Leung SY and Yuen ST: BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res (2003) 63: 4878-4881.
28. Rosenberg DW, Yang S, Pleau DC, Greenspan EJ, Stevens RG, Rajan TV, Heinen CD, Levine J, Zhou Y and O'Brien MJ: Muta tions in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res (2007) 67: 3551-3554.
29. HiraokaS, Kato J, Tatsukawa M, Harada K, FujitaH, Morikawa T, Shiraha H and Shiratori Y: Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras muta tions. Gastroenterology (2006) 131: 379-389.